首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
【24h】

Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.

机译:HaCaT角质形成细胞和其他皮肤细胞中25-羟基维生素D-1α-羟化酶(1alphaOHase,CYP27B1)剪接变体的表达:体外培养条件和UV-B处理的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

In vitro and in vivo studies have demonstrated that the biologically active vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D3, calcitriol) suppresses proliferation and induces differentiation in various cell types, including human keratinocytes and melanocytes. Vitamin D is synthesized in the skin from 7-dehydrocholesterol (7-DHC) by the action of UV-B. There are two principal enzymes involved in the formation of circulating 1,25(OH)2D3 from vitamin D, the hepatic microsomal or mitochondrial vitamin D-25-hydroxylase (CYP27A1) and the renal mitochondrial 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) for vitamin D and 25(OH)D3 (calcidiol), respectively. Extrarenal activity of CYP27B1 has been reported in various cell types including macrophages, keratinocytes, prostate and colon cancer cells. It has been speculated that the extrarenal CYP27B1-mediated local synthesis of 1,25(OH)2D3 represents a key regulator of important cellular functions including growth and differentiation in various cell types and tissues by autocrine or paracrine signalling pathways. The keratinocyte represents the only cell type where the complete enzymatic machinery for the synthesis of 1,25(OH)2D from 7-DHC is present and where the synthesis of 1,25(OH)2D3 from 7-DHC has been shown. In this study, we characterized the pattern of CYP27B1 splice variants in HaCaT keratinocytes in vitro. Applying nested touch-down PCR, the full length CYP27B1 gene product and several additional CYP27B1 splice variants were detected. The pattern of CYP27B1 splice variants varied depending on the cell density, the calcium concentration of the medium ([Ca2+]o), and UV-B treatment. It can be speculated whether increased expression of CYP27B1 splice variants that lack enzymatic activity (Hyd-V3/V5) may result in a reduction of enzymatic activity and in reduced synthesis of 1,25(OH)2D3. Further study of the impact of CYP27B1 splice variants on the vitamin D pathway in keratinocytes and other cell types is warranted.
机译:体外和体内研究表明,具有生物活性的维生素D代谢物1,25-二羟基维生素D(1,25(OH)2D3,骨化三醇)抑制增殖并诱导各种细胞类型的分化,包括人角质形成细胞和黑素细胞。维生素D是通过UV-B的作用由7-脱氢胆固醇(7-DHC)合成的。从维生素D形成循环的1,25(OH)2D3有两种主要酶,肝微粒体或线粒体维生素D-25-羟化酶(CYP27A1)和肾线粒体25-羟维生素D-1α-羟化酶(CYP27B1) )分别用于维生素D和25(OH)D3(骨化二醇)。 CYP27B1的肾外活性在多种细胞类型中都有报道,包括巨噬细胞,角质形成细胞,前列腺和结肠癌细胞。已经推测,肾外CYP27B1介导的1,25(OH)2D3的局部合成代表重要细胞功能的关键调节剂,包括通过自分泌或旁分泌信号途径在各种细胞类型和组织中的生长和分化。角质形成细胞是唯一存在从7-DHC合成1,25(OH)2D的完整酶机制并已显示从7-DHC合成1,25(OH)2D3的细胞类型。在这项研究中,我们表征了HaCaT角质形成细胞中CYP27B1剪接变体的模式。应用巢式触地PCR,检测到全长CYP27B1基因产物和几个其他CYP27B1剪接变体。 CYP27B1剪接变体的模式根据细胞密度,培养基中的钙浓度([Ca2 +] o)和UV-B处理而异。可以推测缺乏酶活性的CYP27B1剪接变体(Hyd-V3 / V5)的表达增加是否会导致酶活性降低和1,25(OH)2D3合成减少。 CYP27B1剪接变体对角质形成细胞和其他细胞类型中维生素D途径的影响的进一步研究值得进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号